MXPA01005808A - Cepa de virus de enfermedad bursal infecciosa para administracion en huevo. - Google Patents

Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.

Info

Publication number
MXPA01005808A
MXPA01005808A MXPA01005808A MXPA01005808A MXPA01005808A MX PA01005808 A MXPA01005808 A MX PA01005808A MX PA01005808 A MXPA01005808 A MX PA01005808A MX PA01005808 A MXPA01005808 A MX PA01005808A MX PA01005808 A MXPA01005808 A MX PA01005808A
Authority
MX
Mexico
Prior art keywords
ovo administration
ibdv strain
strain
ovo
ibdv
Prior art date
Application number
MXPA01005808A
Other languages
English (en)
Inventor
Antonius Wilhelmus Mar Adriaan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MXPA01005808A publication Critical patent/MXPA01005808A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente invencion proporciona un virus de enfermedad bursal infecciosa novedoso, cepa 689, la cual se adapta como candidato para vacuna para la vacunacion in ovo, y esta depositada en la Coleccion Europea de Cultivos Celulares, Salisbury, Wiltshine, Reino Unido, bajo el numero V00012609.
MXPA01005808A 2000-06-09 2001-06-08 Cepa de virus de enfermedad bursal infecciosa para administracion en huevo. MXPA01005808A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202042 2000-06-09

Publications (1)

Publication Number Publication Date
MXPA01005808A true MXPA01005808A (es) 2004-11-10

Family

ID=8171620

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01005808A MXPA01005808A (es) 2000-06-09 2001-06-08 Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.

Country Status (9)

Country Link
US (2) US6451321B1 (es)
JP (1) JP2002045175A (es)
KR (1) KR20020013378A (es)
AU (1) AU782013B2 (es)
BR (1) BR0102322A (es)
CA (1) CA2349960A1 (es)
HU (1) HUP0102389A3 (es)
MX (1) MXPA01005808A (es)
ZA (1) ZA200104596B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
AU2002235158A1 (en) * 2000-12-01 2002-06-11 Vigilos, Inc. System and method for processing video data utilizing motion detection and subdivided video fields
WO2005049794A2 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
WO2005100554A1 (ja) * 2004-03-31 2005-10-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 新規な伝染性ファブリキウス嚢病ウイルス、及び当該ウイルスを含有するワクチン
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
US20100003279A1 (en) * 2005-12-22 2010-01-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccine for in ovo inoculation
RU2561673C2 (ru) * 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
CA2066661C (en) * 1989-10-02 2001-05-08 Craig E. Whitfill Viral vaccine conjugates
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.

Also Published As

Publication number Publication date
CA2349960A1 (en) 2001-12-09
AU782013B2 (en) 2005-06-30
KR20020013378A (ko) 2002-02-20
US20030068334A1 (en) 2003-04-10
AU5179101A (en) 2002-01-03
BR0102322A (pt) 2002-02-13
ZA200104596B (en) 2001-12-06
HUP0102389A2 (hu) 2002-04-29
HUP0102389A3 (en) 2005-06-28
JP2002045175A (ja) 2002-02-12
US6451321B1 (en) 2002-09-17
HU0102389D0 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
AU2001270678A1 (en) Vaccine against foot-and-mouth disease
RU2007130801A (ru) Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs)
HUP0000992A2 (hu) Sejttenyészetben szaporodni képes, géntechnológiailag módosított, fertőző nyálkatömlő-betegséget okozó vírus (IBDV) mutánsai
ES8401128A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral.
TW200503752A (en) HCV vaccines
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
DE3579617D1 (de) Lebender gereinigter impfstoff gegen die marek'sche krankheit.
EP1438066A4 (en) IMMUNOGENIC COMPOSITIONS OF ENTIRE CELLS OF REACTIVE BACTERIA
EP1161953A3 (en) IBDV strain for in OVO administration
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
MXPA02003328A (es) Vacuna.
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
CA2273074A1 (en) In ovo vaccination against newcastle disease
MX9602256A (es) Vacuna contra la enfermedad de marek.
WO2000012677A3 (en) Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
EP1038952A3 (en) Processes for preparation of Marek's Disease Virus using continuous avian cell lines
HU0102823D0 (en) A broad spectrum infectious bursal disease virus vaccine
CA2499430A1 (en) Chicken astrovirus type 2
EP1074624A4 (en) GENE 62 OF THE ATTENUATED VARICELLA VIRUS STRAIN OKA AND METHOD FOR IDENTIFYING THE VIRUS STRAIN ATTENUATED VARICELLA VACCINE USING THE SAME
EP0496787A4 (en) Novel infectious bursal disease virus
AP2005A (en) Process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype C isolates, their genes and modifications and derivatives thereof.
NZ510130A (en) Chicken anaemia viruses of low pathogenicity